🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral GLP-1 for elderly patients — anyone have experience? Page 8

Oral GLP-1 for elderly patients — anyone have experience?

EndoResFellow Sat, Jul 12, 2025 at 4:27 AM 45 replies 2,071 viewsPage 8 of 9
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Jul 25, 2025 at 8:44 PM#36
TrialNerd_Beth said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

There is a second half to this that has not been said yet. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

1 24VendorMark
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Jul 26, 2025 at 11:10 AM#37

The figures, for anyone assembling their own picture. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

Last edited: Jul 26, 2025 at 3:10 PM
2 0dave_SLC, FDA_TrackerJim
Reply Quote Save Share Report
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Jul 27, 2025 at 1:36 AM#38

A narrower follow-up, since the general answer is now clear:

Was that from a primary source or from a summary of one?

3 1ricardo_MIA, BrianDallas92, labquiet_amy
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Jul 27, 2025 at 4:03 PM#39
PeptideChemSF said:
Practical: whatever you change, write down the date and the reason.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

Last edited: Jul 27, 2025 at 10:03 PM
4 2DanielChem_CHI, marco_milano, pam_columbus and 1 other
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Jul 28, 2025 at 6:30 AM#40
PeptideChemSF said:
Practical: whatever you change, write down the date and the reason.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

Correct me if the detail matters more than I have assumed.

26 24DeniseRN_TPA, SandraNC_45, Dr.EndoIndy and 23 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register